Total raised
$8.0M
Last: Seed 2025-05
Stage
Seed
Founded
2022
Headcount
10
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
Alphabiome uses artificial intelligence to decode the genetic complexity of the human microbiome and identify biomarkers that predict treatment efficacy. Alphabiome’s mission is to unlock the full potential of the microbiome to transform how diseases are understood, diagnosed, and treated . Its proprietary technology enables large-scale, reference-free analysis of microbial DNA – converting trillions of untapped genetic fragments into actionable insights for drug development, clinical decision-making, and precision medicine.
Funding history · 4 rounds · $8.0M total
2025-05
Seed
$8.0M
2024-07
Seed
Undisclosed
2024-04
SAFE
Undisclosed
2022-06
Convertible Debt
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life Sciences
Technologies
Artificial Intelligence
Target customers
Healthcare & Life Sciences
Business model
B2B
Highlights
Verified
Tags
artificial-intelligencebiomarkersmicrobiomeprecision-medicinegenomicsmicrobiologyhealthcarebiotechnologypersonalized-medicine